Endo-SPONGE for Treatment of Anastomotic or Hartmann's Stump Leakages in Lower Pelvic Area
A Prospective Multicenter Trial Evaluating the Safety and Effectiveness of Endo-SPONGE for the Treatment of Anastomotic or Hartmann's Stump Leakages in the Lower Pelvic Area
- Anastomotic Leaks
- Hartmanns Stump Leakage
At a glance
- Phase
- Phase not stated
- Study type
- Interventional
- Sponsor
- Boston Scientific Corporation
- Enrolment target
- 66
- Started
- October 2026
- Main results due
- December 2028
- Study sites
- 10
- Registry updated
- 24 September 2026
Can you take part?
- Aged 18 years and over.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: * Confirmed grade B anastomotic leak as per the ISGRC (International Study Group of Rectal Cancer) grading system after colorectal surgery. * Subject is eligible for endoscopic intervention. * Subject has a transmural defect of at least 2 cm in diameter following colorectal surgery in the lower pelvic area. * Subject has an anastomotic or Hartmann's stump leak located within an extraperitoneal cavity. * Subject has pre-existing diverting ostomy or an ostomy created prior to the first Endo-SPONGE placement. * Subject understands the trial requirements and is willing and able to comply with the study procedures, all protocol-required follow up evaluations and provide written informed consent to participate in the study. * Investigator decision that EVT is the most suitable treatment of the available treatment options. Exclusion Criteria: * Subject is under 18 years of age. * Potentially vulnerable subject, including, but not limited to pregnant women. * Subject has undergone EVT or other similar interventions for the current colorectal indication. * Subject had colorectal surgery more than 60 days prior to the planned study procedure. * Subject has any necrotic tissue that would require endoscopic debridement prior to Endo-SPONGE placement. * Subject has known contraindication for EVT as per the IB. * Subject is currently enrolled in another investigational study that would directly interfere with the current study, without prior written approval from the sponsor.
What this study is about
In the sponsor’s own words, from the registry.
This study is intended to evaluate the safety and effectiveness of Sponge-based Endoscopic Vacuum Therapy (EVT) using Endo-SPONGE for the treatment of Anastomotic Leaks (AL) or Hartmann's stump leakages following colorectal surgery in a prospective multi-center study.
Study sites(10)
University of California, Davis Medical Center
Sacramento, California, United States
Not yet recruiting
Orlando Regional Medical Center
Orlando, Florida, United States
Not yet recruiting
Cleveland Clinic Florida
Weston, Florida, United States
Not yet recruiting
Lahey Medical Center
Burlington, Massachusetts, United States
Not yet recruiting
Mount Sinai
New York, New York, United States
Recruiting
Cleveland Clinic Foundation
Cleveland, Ohio, United States
Not yet recruiting
Penn State Health
Hershey, Pennsylvania, United States
Recruiting
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
Not yet recruiting
University of Washington Medical Center
Seattle, Washington, United States
Recruiting
Marshall University Medical Center
Huntington, West Virginia, United States
Recruiting
Showing 10 of 10 sites. 4 of the 10 sites on this study are recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT07035431. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me